Updated Covid booster shots will be important for shoring up population immunity as new variants emerge, suggests a study.
However, the trick is to target a variant for the booster that is so different from the original strain of the virus that it triggers the maturation of new and diverse antibody-producing cells, said scientists from the Washington University School of Medicine in St. Louis.
The first Covid vaccines reduced the risk of severe illness and death by more than 90 per cent. But then the virus changed. The antibodies that had worked so well against the original strain proved less effective at recognising and neutralising emerging variants, leading to breakthrough infections.
The obvious solution was to update the vaccines to target new variants, but the success of the first vaccines against the original strain made designing an effective variant booster shot tricky, said Ali Ellebedy, Associate Professor of pathology and immunology, of medicine, and of molecular microbiology at the varsity.
In the study, published in the journal Nature, the team showed that it's possible to design a variant-specific booster that doesn't just strengthen the antibodies people already have but elicits new antibodies.
"This means that periodically giving boosters targeting new variants would allow population-level protection to be maintained even as the virus evolves," Ellebedy said.
"The whole point of making boosters against new variants is to teach the immune system to recognise features in the new variants that are different from the original strain.
"But the new variants still share a lot of features with the original strain, and it's possible that the response to these shared features could dominate the response to new features. The boosters could end up just engaging immune memory cells that are already present rather than creating new memory cells, which is what we need for protection against new variants," he said.
To gauge the effectiveness of boosters at eliciting new antibodies, the researchers looked at 39 people who had received the two-shot primary sequence of the Pfizer/BioNTech or Moderna Covid-19 vaccines, followed by an experimental booster shot targeting the Beta and Delta variants.
All participants produced antibodies that neutralised the original virus strain and the Beta and Delta variants. But none of the antibodies studied were unique to Beta or Delta. The absence of such antibodies indicates that the variant booster had failed to trigger the development of detectable new antibody-producing cells, Ellebedy said.
Further, Ellebedy and team recruited eight people who had received the Pfizer/BioNTech or Moderna Covid-19 vaccine and gave them a booster targeted against the Omicron variant alone.
Studying blood samples provided by participants four months after their boosters, the researchers identified more than 300 distinct antibodies capable of neutralising the original strain, or one or more of the variants.
Of those, six neutralised Omicron but not the original strain, an indication that the booster successfully triggered the creation of new antibodies optimised for Omicron.
New Urban Community Health Centre to reduce patients rush in GBP Hospital: CM Dr Manik Saha
Chief Minister Dr Manik Saha on Thursday laid foundation stone of 50-bed Urban Community Health Center here at Agartala and said that the present government is working diligently to improve health infrastructure and services in the state.
Govt determined to develop sports infrastructure in Tripura: CM Dr Manik Saha
Chief Minister Dr Manik Saha on Thursday inaugurated football turf, athletics track and hockey ground here at Agartala Dasarath Deb Sports Complex at Badharghat and said that the government is determined to develop facilities and platform for sports persons in the state.
Mistake that benefits no one: World leaders react to Trump's 'reciprocal tariffs'
As US President Donald Trump signed an executive order on the so-called "reciprocal tariffs," the world reacted sharply against the decision, with some calling it a "mistake that benefits no one" while others called it a violation of Washington's obligations under the World Trade Organization (WTO).
Indian pharmaceutical exports get reprieve from Trump’s reciprocal tariffs
Because of the importance of India’s pharmaceuticals to US healthcare, those exports will get a reprieve from President Donald Trump’s reciprocal tariffs, according to the White House.
India stands less impacted by Trump tariffs than global peers: Industry
As US President Donald Trump announced reciprocal tariffs on dozens of countries, including India, industry experts said on Thursday that it appears India's export competitiveness to the US market stands far less impacted on a relative basis compared to global peers.
IAF pilot killed, another critical as Jaguar fighter jet crashes in Gujarat
An Indian Air Force (IAF) pilot lost his life, while another sustained critical injuries after their two-seater Jaguar fighter jet crashed near Gujarat's Jamnagar Airfield, the IAF confirmed on Thursday.
PM Modi emplanes for Thailand; to attend BIMSTEC summit
Prime Minister Narendra Modi on Thursday emplaned for Thailand on a state visit to attend the 6th BIMSTEC Summit, with his visit also set to bolster bilateral relations between New Delhi and Bangkok.
Bhavan’s Little Learners celebrate annual programme
The Bhavan’s Little Learners, Bordowali celebrated annual programme and organised prize distribution ceremony here at Agartala Rabindra Satabarshiki Bhavan on Wednesday.